Review





Similar Products

crispr-cas9 crrna  (Integrated DNA Technologies)
95
Integrated DNA Technologies crispr-cas9 crrna
Crispr Cas9 Crrna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/CRISPR-Cas9+crRNA/custom%40crispr-cas9-crrna%4042830950
Average 95 stars, based on 1 article reviews
crispr-cas9 crrna - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
crispr cas9 technology  (Addgene inc)
96
Addgene inc crispr cas9 technology
Crispr Cas9 Technology, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/CRISPR-SP-Cas9+reporter+(Plasmid+%2362733)/pmc13655266-399-0-8
Average 96 stars, based on 1 article reviews
crispr cas9 technology - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
human plenticrispr v2 pooled ko library brunello  (Addgene inc)
96
Addgene inc human plenticrispr v2 pooled ko library brunello
Human Plenticrispr V2 Pooled Ko Library Brunello, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/Human+CRISPR+Knockout+Pooled+Library+(Brunello)+(Pooled+Library+%2373179%2C+%2373179-LV%2C+%2373178%2C+%2373178-LV)/pm42834166-385-1-16
Average 96 stars, based on 1 article reviews
human plenticrispr v2 pooled ko library brunello - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
small guide rnas sgrnas  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology small guide rnas sgrnas
(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing <t>RNAs;</t> ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .
Small Guide Rnas Sgrnas, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/Nanos3+CRISPR%2FCas9+KO+Plasmid/pmc13641165-565-6-10
Average 93 stars, based on 1 article reviews
small guide rnas sgrnas - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
lenti crispr cas9v2 vector  (Addgene inc)
96
Addgene inc lenti crispr cas9v2 vector
(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing <t>RNAs;</t> ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .
Lenti Crispr Cas9v2 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/lentiCRISPR+v2+(Plasmid+%2352961)/pm42815467-382-31-34
Average 96 stars, based on 1 article reviews
lenti crispr cas9v2 vector - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
toronto knockout v3 tkov3 genome scale crispr library  (Addgene inc)
94
Addgene inc toronto knockout v3 tkov3 genome scale crispr library
(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing <t>RNAs;</t> ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .
Toronto Knockout V3 Tkov3 Genome Scale Crispr Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/Toronto+KnockOut+(TKO)+CRISPR+Library+-+Version+3+(Pooled+Libraries+%2390294%2C+%23125517)/pm42789393-1097-1-8
Average 94 stars, based on 1 article reviews
toronto knockout v3 tkov3 genome scale crispr library - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
crispr cas9 sgrna vector pdd162  (Addgene inc)
95
Addgene inc crispr cas9 sgrna vector pdd162
(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing <t>RNAs;</t> ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .
Crispr Cas9 Sgrna Vector Pdd162, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/pDD162+(Peft-3%3A%3ACas9+%2B+Empty+sgRNA)+(Plasmid+%2347549)/pm42771683-522-13-16
Average 95 stars, based on 1 article reviews
crispr cas9 sgrna vector pdd162 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
toronto knockout version 3 0 tkov3 guide rna guide rna grna 106 library  (Addgene inc)
94
Addgene inc toronto knockout version 3 0 tkov3 guide rna guide rna grna 106 library
(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing <t>RNAs;</t> ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .
Toronto Knockout Version 3 0 Tkov3 Guide Rna Guide Rna Grna 106 Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/Toronto+KnockOut+(TKO)+CRISPR+Library+-+Version+3+(Pooled+Libraries+%2390294%2C+%23125517)/10__1158_slash_2767___9764__crc___26___0150-55-12-22
Average 94 stars, based on 1 article reviews
toronto knockout version 3 0 tkov3 guide rna guide rna grna 106 library - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
crispr cas12a  (New England Biolabs)
99
New England Biolabs crispr cas12a
(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing <t>RNAs;</t> ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .
Crispr Cas12a, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/EnGen+Lba+Cas12a/pm42763149-47-0-8
Average 99 stars, based on 1 article reviews
crispr cas12a - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
crispr cas9 knockout ko system stable cell line gapdh knockout ko  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology crispr cas9 knockout ko system stable cell line gapdh knockout ko
(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing <t>RNAs;</t> ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .
Crispr Cas9 Knockout Ko System Stable Cell Line Gapdh Knockout Ko, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr/GAPDH+CRISPR%2FCas9+KO+Plasmid/pm42546543-118-0-27
Average 92 stars, based on 1 article reviews
crispr cas9 knockout ko system stable cell line gapdh knockout ko - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

Image Search Results


(A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing RNAs; ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .

Journal: Molecular cell

Article Title: DND1–NANOS3 shapes the PGC transcriptome via a heptanucleotide sequence in mRNA 3′-UTRs

doi: 10.1016/j.molcel.2026.09.010

Figure Lengend Snippet: (A) DND1 (purple) and NANOS3 (pink) residues interacting with the N3-DRE. Filled shading, residues substituted with alanine for functional analysis. (B) DND1–NANOS3 co-expression constructs with indicated mutations (top) or truncations (bottom). (C) Schematic of assays performed with cells expressing constructs from (B). (D) Assay results for DND1–NANOS3 constructs with DND1 point mutants: ( 1 ) IncuCyte growth assays; ( 2 ) expression of N3-DRE-containing RNAs; ( 3 ) protein levels of N3-DRE-containing targets (CDK1, EHMT2, and CNOT6; immunoblots in Fig. S5 ). (E) As in (D), with NANOS3 point mutations. (F) DND1 K196A loses selectivity for the N3-DRE G3 nucleotide in vitro . Error bars, K d confidence interval from MST data fitting. (G) As in (D), with DND1 or NANOS3 truncations. (H) Effects of DND1/NANOS3 mutations or deletions on RNA turnover. Left, median fold changes in k deg for each N3-DRE class, normalized to the corresponding No motif group. Middle, median fold changes in k syn . Right, median fold changes in transcript half-life. Corresponding violin plots and CDFs are shown in Figures S5F and S5G . (I) Summary of the functional impact of RNA-binding residue mutations and IDR deletion. Statistics (D-F): Cell growth: Scale bar, 400 μm (bottom right image only). CDFs: n, number of genes; ML, median log 2 -fold change; δ, Cliff’s delta; p , two-sided Wilcoxon rank-sum test. Protein quantification: Error bars indicate S.D. Two-sided Student’s t -test ( n = 3 independent experiments). Exact p -values are provided in Source Data. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. See also Figure S5 and Table S1 .

Article Snippet: We purchased a cocktail of three small guide RNAs (sgRNAs) (Santa Cruz Biotechnology, Inc., sc-434074), cloned individual sgRNA plasmids, and used pairs of the sgRNAs for the targeted deletions of the ZF region of the Nanos3 locus.

Techniques: RNA Binding Assay, Functional Assay, Analysis, Expressing, Construct, Western Blot, In Vitro, Residue